Plain-English translation of NCT06476678 on ClinicalTrials.gov β Β· Source last updated Β· Translation generated Β· How we translate trials
This trial is testing a novel bipolar radiofrequency ablation knife β a specialized cutting tool used during endoscopic submucosal dissection (a minimally invasive procedure to remove precancerous growths from your esophagus). The new tool uses lower energy than traditional cutting instruments, which may reduce complications like pain, infection, and scarring that patients sometimes experience after this type of procedure.
Currently, doctors use traditional cutting tools that generate a lot of heat, leading to post-procedure complications in up to 40% of patients β including pain, fever, and the need for blood thinners and antibiotics. Additionally, when large areas are treated, patients often develop strictures (narrowing of the esophagus) that require repeated stretching procedures. This new treatment is designed to accomplish the same removal goal with less tissue damage and fewer complications.
You likely qualify ifβ¦
You likely don't qualify ifβ¦
If you are selected for this trial, you will undergo an endoscopic submucosal dissection procedure using the new bipolar radiofrequency ablation knife to remove your precancerous growth. During the procedure, your doctor will mark the area, inject fluid to lift the lesion, make careful cuts around it, and then remove it completely β all through your mouth without surgery. The trial will evaluate how well the new tool works and whether it reduces the complications patients typically experience with traditional tools.
AI-generated summary from trial data Β· Jun 2, 2026 Β· Not medical advice
United States
Sponsor
Baylor College of Medicine
Collaborators
Creo Medical Limited
Enrollment target
~50 participants
Started
October 2024
Primary completion
June 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in March 2026.
Reach out to the team running this trial. Response times vary β some teams are faster than others.
Central contact
Salmaan A Jawaid, MD
Baylor College of Medicine
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first β no email needed to get started.